InvestorsHub Logo

$heff

02/23/12 11:16 AM

#52039 RE: $heff #52026

HZNP..$3.61 Horizon Pharma announced that it has entered into a loan agreement with a group of lenders to provide $60 mln in capital (HZNP) 3.10 -0.19 : CO used $22.4 mln of the loan proceeds to repay the remaining obligations under its loan agreements with Oxford Finance LLC, Silicon Valley Bank and Kreos Capital, and expects to use the remainder of the capital to fund the ongoing commercial launch of DUEXIS in the U.S., and to pursue regulatory approval for DUEXIS in Europe and LODOTRA in the U.S.